Orthopaedic Management Improves the Rate of Early Osteoporosis Treatment After Hip Fracture
- 1 November 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Bone and Joint Surgery
- Vol. 90 (11), 2346-2353
- https://doi.org/10.2106/jbjs.g.01246
Abstract
Background: Although osteoporosis is strongly associated with hip fractures, the initiation of osteoporosis treatment following hip fractures occurs at surprisingly low rates of between 5% and 30%. Currently, most patients receiving treatment have been referred back to their primary care physician for osteoporosis management. The purpose of this study was to compare the effect of osteoporosis management initiated by the orthopaedic team and osteoporosis management initiated by the primary care physician on the rates of treatment at six months. Methods: A prospective randomized trial was conducted to assess the difference in the rate of osteoporosis treatment when an in-house assessment of osteoporosis was initiated by the orthopaedic surgeon and follow-up was conducted in a specialized orthopaedic osteoporosis clinic compared with osteoporosis education and “usual” care. Results: Sixty-two patients were enrolled in the study. Thirty-one patients each were in the control and intervention groups. The percentage of patients who were on pharmacologic treatment for osteoporosis at six months after the fracture was significantly greater when the evaluation was initiated by the orthopaedic surgeon and was managed in a specialized orthopaedic osteoporosis clinic (58%) than when treatment was managed by a primary care physician (29%) (p = 0.04). Conclusions: An active role by orthopaedic surgeons in the management of osteoporosis improves the rate of treatment at six months following a hip fracture. Level of Evidence: Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence.Keywords
This publication has 35 references indexed in Scilit:
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureNew England Journal of Medicine, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 2007
- Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital dischargeJournal of the American College of Cardiology, 2004
- Hip fracture patients are not treated for osteoporosis: A call to actionArthritis Care & Research, 2002
- Patient Barriers to Osteoporosis Interventions After FractureMayo Clinic Proceedings, 2002
- Barriers to Osteoporosis Identification and Treatment Among Primary Care Physicians and Orthopedic SurgeonsMayo Clinic Proceedings, 2002
- Shear-Induced First-Order Sponge-to-Lamellar Transition in a Lyotropic Surfactant SystemPhysical Review Letters, 2001
- Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention TrialJournal of Clinical Endocrinology & Metabolism, 2000
- Fractures Attributable to Osteoporosis: Report from the National Osteoporosis FoundationJournal of Bone and Mineral Research, 1997
- The Prevention and Treatment of OsteoporosisNew England Journal of Medicine, 1992